BR100 Increased By (0.44%)
BR30 Increased By (1.39%)
KSE100 Increased By (0.62%)
KSE30 Increased By (0.61%)
BECO 5.49 No Change ▼ 0.00 (0%)
BML 56.00 Decreased By ▼ -0.76 (-1.34%)
BOP 35.41 Increased By ▲ 0.29 (0.83%)
CNERGY 8.20 Increased By ▲ 0.05 (0.61%)
DCL 11.55 Increased By ▲ 0.04 (0.35%)
FCCL 58.15 Increased By ▲ 1.40 (2.47%)
FCSC 5.15 No Change ▼ 0.00 (0%)
FFL 17.90 Increased By ▲ 0.02 (0.11%)
FNEL 1.25 No Change ▼ 0.00 (0%)
HUMNL 11.10 Decreased By ▼ -0.02 (-0.18%)
KEL 8.56 Increased By ▲ 0.14 (1.66%)
KOSM 6.75 Increased By ▲ 0.17 (2.58%)
MLCF 105.65 Increased By ▲ 2.35 (2.27%)
NBP 202.10 Increased By ▲ 1.92 (0.96%)
PACE 11.28 Decreased By ▼ -0.01 (-0.09%)
PAEL 44.42 Increased By ▲ 0.95 (2.19%)
PIAHCLA 28.66 Increased By ▲ 1.17 (4.26%)
PIBTL 18.75 Increased By ▲ 1.05 (5.93%)
PPL 248.10 Increased By ▲ 3.78 (1.55%)
PRL 35.35 Decreased By ▼ -0.08 (-0.23%)
PTC 66.15 Increased By ▲ 0.80 (1.22%)
SEARL 94.95 Increased By ▲ 1.63 (1.75%)
SSGC 32.04 Decreased By ▼ -0.90 (-2.73%)
TELE 8.93 Increased By ▲ 0.02 (0.22%)
THCCL 66.65 Decreased By ▼ -0.07 (-0.1%)
TPLP 10.76 Decreased By ▼ -0.07 (-0.65%)
TREET 25.22 Increased By ▲ 0.10 (0.4%)
TRG 64.21 Decreased By ▼ -0.69 (-1.06%)
WAVES 10.85 Decreased By ▼ -0.08 (-0.73%)
WTL 1.27 Increased By ▲ 0.02 (1.6%)
World

Ukrainian firm applies to make Russia's COVID-19 vaccine, sparking political dilemma

  • Ukraine's government has played down the prospects of approving the Sputnik V vaccine quickly, if at all.
  • I am not going to assess the chances of the Biolik company," Stepanov said by phone.
Published January 6, 2021 Updated January 6, 2021 09:09pm
By

KYIV: A Ukrainian pharmaceutical company backed by a prominent Russian-leaning opposition figure has applied for state approval to make Russia's Sputnik V COVID-19 vaccine, a sensitive move given toxic relations between Kyiv and Moscow.

The two countries have been at loggerheads since Russia's annexation of Crimea from Ukraine in 2014 and involvement in a conflict in Ukraine's eastern Donbass region which Kyiv says has killed 14,000 people.

Ukraine's government has played down the prospects of approving the Sputnik V vaccine quickly, if at all.

Health Minister Maksym Stepanov told Reuters the issue was being used as "political PR" by some forces and as part of Russia's "hybrid warfare" against Ukraine.

Ukrainian pharmaceutical firm Biolik said in a statement on its website it had applied to register Gam-COVID-Vac, also known as Sputnik V, in Ukraine. Russia on Saturday floated the idea of holding clinical trials in Ukraine.

"I am not going to assess the chances of the Biolik company," Stepanov said by phone. "It would be very mild to say that we are not sure about the Russian vaccine. We do not know how the research was carried out."

Biolik's application has been promoted by the Ukrainian opposition politician Viktor Medvedchuk, an ally of Russian President Vladimir Putin.

Deputy Health Minister Viktor Lyashko was quoted by Interfax news agency as saying Ukraine would only use vaccines that had finished clinical trials. Sputnik V is still undergoing Phase III trials.

Ukrainian President Volodymyr Zelenskiy told the New York Times last month that the vaccine would be used in Russia's "information war" against Ukraine.

But he was also quoted as saying "...it is impossible to explain to Ukrainian society why not take the vaccine from Russia if America and Europe do not give you the vaccine. It is impossible to explain that to anyone who dies."

Zelenskiy's government expects to receive COVID-19 vaccines from China and the global COVAX scheme for poorer nations to fight the pandemic.

Stepanov said Ukraine would sign more contracts with trusted manufacturers in the near future.

Comments

Comments are closed for this article.